FDA Reviews Arthritis Drugs for Cancer Link
Links shared publicly online about this topic
FDA: Arthritis drugs pose cancer risk to kids - Arthritis- msnbc.com
msnbc.msn.com — “Federal regulators added stronger warnings to a group of best-selling drugs used to treat arthritis and other inflammatory diseases, saying they can increase the risk of cancer in children and adolescents.” View full resource at msnbc.msn.com
Most Recently Shared on August 4, 2009 at 7:49 pm By:
msnbc.com - Health Health News
FDA: Arthritis drugs pose cancer risk to kids http://bit.ly/rDJv5
Arthritis drugs raise cancer risk in kids: FDA | Reuters
feeds.reuters.com — “WASHINGTON (Reuters) - Blockbuster prescription drugs used to treat rheumatoid arthritis and other conditions can increase the risk of potentially deadly cancer in children and teenagers, U.S. health regulators” View full resource at feeds.reuters.com
Most Recently Shared on August 5, 2009 at 3:15 pm By:
Arthritis drugs raise cancer risk in kids: FDA http://link.reuters.com/buj89c
Arthritis drugs raise cancer risk in kids: FDA | Reuters
feeds.reuters.com — “WASHINGTON (Reuters) - Blockbuster prescription drugs used to treat rheumatoid arthritis and other conditions can increase the risk of potentially deadly cancer in children and teenagers, U.S. health regulators” View full resource at feeds.reuters.com
Most Recently Shared on August 4, 2009 at 9:15 pm By:
Arthritis drugs raise cancer risk in kids: FDA http://link.reuters.com/mez79c
Arthritis drugs raise cancer risk in kids: FDA | Reuters
feeds.reuters.com — “WASHINGTON (Reuters) - Prescription drugs used to treat rheumatoid arthritis and other conditions can increase the risk of potentially deadly cancer in children and teenagers, U.S. health regulators said” View full resource at feeds.reuters.com
Most Recently Shared on August 4, 2009 at 7:15 pm By:
Arthritis drugs raise cancer risk in kids: FDA http://link.reuters.com/nex79c
FDA staff question Pfizer arthritis drug benefits | Reuters
in.reuters.com — “WASHINGTON (Reuters) - U.S. drug reviewers on Monday questioned whether the benefits of Pfizer Inc's experimental treatment for rheumatoid arthritis outweighed its risks of cancerous cells and infections.The” View full resource at in.reuters.com
Most Recently Shared on May 7, 2012 at 2:36 pm By:
FDA staff question Pfizer arthritis drug benefits http://t.co/WXFuqyft
FDA to Explore Possible Vytorin-Cancer Link
webmd.com — “The FDA is investigating a report from the SEAS trial of a possible association between use of the drug Vytorin and increased cancer risk.” View full resource at webmd.com
Most Recently Shared on August 22, 2008 at 2:22 am By:
WebMD Health News FDA to Explore Possible Vytorin-Cancer Link: The FDA is investigati.. http://tinyurl.com/6nqy3r
FDA Drug Safety Communication: Update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer
fda.gov — “[1-12-2011] The U.S. Food and Drug Administration (FDA) is updating the public about its ongoing safety review of Lantus (insulin glargine) and a possible increased risk of cancer.” View full resource at fda.gov
Most Recently Shared on January 13, 2011 at 2:37 pm By:
NCI Cancer Bulletin Health News
FDA provides update on review of possible link between diabetes drug, cancer risk: http://bit.ly/hVDraB
FDA Issues Warning for Some Juvenile Rheumatoid Arthritis Drugs - TNF Blockers May Boost Kids' Cancer Risk
spineuniverse.com — “The US Food and Drug Administration (FDA)announced that TNF blockers, a class of drugs commonly used to treat juvenile rheumatoid arthritis and ankylosing spondylitis, may increase the risk of cancer in children and young adults.” View full resource at spineuniverse.com
Most Recently Shared on August 12, 2009 at 8:16 pm By:
FDA warns about TNF blockers for juvenile rheumatoid arthritis--but how concerned should you be? http://bit.ly/JhWnp
As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution:
health.msn.com — “As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution:” View full resource at health.msn.com
Most Recently Shared on May 4, 2010 at 7:55 pm By:
As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution: http://bit.ly/9dDywc
As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution - Drugs.com MedNews
drugs.com — “When the U.S. Food and Drug Administration announced Monday it was investigating possible links between widely used hormonal prostate cancer drugs and an slight” View full resource at drugs.com
Most Recently Shared on May 4, 2010 at 11:24 pm By:
As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution - http://bit.ly/aM38UT
FDA to Review Safety of Sanofi Drug - WSJ.com
online.wsj.com — “The FDA advised patients to continue taking Sanofi-Aventis's Lantus, despite recent studies showing the diabetes drug may be linked to cancer risks.” View full resource at online.wsj.com
Most Recently Shared on July 1, 2009 at 4:23 pm By:
FDA to Review Sanofi Drug's Safety http://tinyurl.com/ks2hxb
FDA reviewing safety of Actos diabetes drug: The Food and Drug Administration said on Friday it was reviewing if T... http://bit.ly/d4BM97
health.yahoo.net — “FDA reviewing safety of Actos diabetes drug: The Food and Drug Administration said on Friday it was reviewing if T... http://bit.ly/d4BM97” View full resource at health.yahoo.net
Most Recently Shared on September 17, 2010 at 10:57 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
FDA reviewing safety of Actos diabetes drug: The Food and Drug Administration said on Friday it was reviewing if T... http://bit.ly/d4BM97
FDA, medical societies warn of possible link between diabetes drug, bladder cancer risk | HemOncToday
hemonctoday.com — “After reviewing data from a 5-year interim analysis of an ongoing, 10-year epidemiological study, the FDA is informing the public of a possible” View full resource at hemonctoday.com
Most Recently Shared on June 17, 2011 at 7:51 pm By:
HemOnc Today Oncology and Health News
#FDA, medical societies warn of possible link between #diabetes drug, bladder cancer risk http://t.co/aHMiBBC
Diabetes Drug Actos (pioglitazone) Review Initiated To Determine Possible Bladder Cancer Link - QualityPoint Technologies
qualitypointtech.net — “Actos (pioglitazone), a diabetes medication is being reviewed by the FDA (Food and Drug Administration) after it received a long-term observational study which evaluated the risk of bladder cancer. The preliminary results of the 10-year observational long-term study are based on five-year data gathered by Takeda Pharmaceuticals North America Inc., San Diego. Pioglitazone is used along with diet and exercise to control blood sugar or improve control of blood sugar in patients with Type 2 Diabetes” View full resource at qualitypointtech.net
Most Recently Shared on September 18, 2010 at 8:49 pm By:
Diabetes Drug Actos (pioglitazone) Review Initiated To Determine Possible Bladder Cancer Link: Actos (pioglitazone... http://bit.ly/aOHwmC
No proof Vytorin causes cancer, FDA says - Health- msnbc.com
msnbc.msn.com — “Federal drug regulators say an extensive data review shows there's no evidence that Merck's cholesterol drug Vytorin causes cancer, a suspicion raised last year by a patient study.” View full resource at msnbc.msn.com
Most Recently Shared on December 22, 2009 at 6:32 pm By:
msnbc.com - Health Health News
No proof Vytorin causes cancer, FDA says http://bit.ly/8MtuL0
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
msnbc.com - Health
Health, diet and nutrition news from msnbc.com
-
Reuters Health
-
Reuters Health
Advertisement
